Health Care Disparities
Precision medicine based on genetic makeup of tumors is leading to anticancer treatments that target specific patients; however, racial and ethnic minorities are underrepresented in genomic samples, resulting in less benefit from advances in cancer care for these patients.
Offering free screening colonoscopies can identify CRC earlier in uninsured patients who are at high risk for developing the disease. In addition, the program is cost neutral from the perspective of a hospital system.
Disparities in cancer risk management among BRCA carriers across a diverse sample of young black, Hispanic, and non-Hispanic white breast cancer survivors underscores that "the benefit from genetic testing comes from acting on the test results," not just the testing itself, a study presented at the ASCO 2016 Annual Meeting concluded.
"In the absence of patient-matched germline data, large germline databases are required in analysis workflows to minimize false positive mutation calling and mitigate ethnic disparities," a study presented at the ASCO 2016 Annual Meeting concluded.
A study of nearly 1000 patients with HCC found that black patients with the disease had a 33% greater risk of death compared with non-Hispanic whites.
Treatment gap exists, but the reasons for the care disparity aren't entirely clear.
Disparities in BRCA1/2 testing in black and white women is attributable to differences in physician recommendations, according to a recent study.
A new report from the U.S. Department of Health and Human Services finds improvements to infant mortality rates and number of insured citizens, but other problem areas persist.
Clear role expectations and organization support are vital for lay health advisors.
Several genetic differences uncovered in an analysis of data from The Cancer Genome Atlas (TCGA) are biologically plausible contributing factors for the worse survival of African American patients with clear cell renal carcinoma, even in the era of targeted therapy.
Disparities in some cancer mortality rates between African Americans and whites in the United States have decreased, but these differences remain in colorectal and breast cancers.
The 90-day reoperation rate for breast conserving surgery dropped from 40 to nearly 25 percent and varies depending on surgeon, according to recent research.
HPV-positive oropharyngeal cancer prevalence varies between Western Europe and Eastern Europe, according to study data.
Racial and ethnic variation is evident in lung cancer incidence and mortality among postmenopausal women, but other factors may also have an influence, according to a recent study.
Hospital-based physicians exhibit significantly fewer positive, rapport-building nonverbal cues with black patients than with white patients when discussing end-of-life care.
Health care system and societal factors are critical components leading to health disparities, as revealed in a new report that focuses on cancer in people with mental illness.
Older black men with localized prostate cancer were more likely to have poorer quality care, incur higher costs, and have worse postoperative outcomes than white men. However, that did not translate to worse overall or cancer-specific survival.
Cancer trial participation decreases with decreasing annual household income, according to recent data.
Many breast cancer survivors in Appalachia neglect taking critical follow-up treatment, even though their insurance would cover the cost, a study has found.
Women contribute approximately $3 trillion to health care globally, much of which is unrecognized.
After 2008 a rise was seen in screening for colorectal cancer (CRC) for lower socioeconomic status persons, possibly reflecting the Affordable Care Act's removal of financial barriers to screening.
Rates of health insurance coverage vary depending on patient demographics, such as race and marital status, as well as cancer type.
Although racial disparities for cancer are decreasing, cancer mortality among African Americans as a group remains elevated.
California and New York fully expanded Medicaid coverage under ACA, but Texas and Florida did not.
Chemotherapy fees for uninsured patients can be 43 times more than those seen for insured patients.
The LGBTQI community experience health disparities due to reduced access to health care and insurance, coupled with an elevated risk for multiple types of cancer compared with non-LGBTQI populations, according to recent research.
Racial and ethnic differences extend to how surgeons and hospitals for breast cancer care are selectedApril 06, 2015
Black and Hispanic women with breast cancer were less likely to use reputation as a factor ins selecting their surgeon or hospital for treatment, when compared with white women.
Household net worth can be linked to adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care.
Brain tumor patients who are uninsured or use Medicaid stay hospitalized longer and develop more medical complications than those with private insurance, according to a new study.
A federal prescription-subsidy program for low-income Medicare recipients has increased adherence to hormone therapy to prevent breast cancer recurrence after surgery, according to recent data.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- LIVESTRONG Exercise Program Improves QoL in Cancer Survivors
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|